The effectiveness of probiotics on asthmatic patients

Phase 3

• Conditions: Asthma.; J45.3; Mild persistent asthma

• Registration Number: IRCT20220329054368N1
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients between 10 - 18 years
A well-known case of persistent moderate asthma that has just been diagnosed and, has a medical record and approval from an asthma and allergy specialist.
All patients are taking fluticasone spray.
Have no history of other respiratory illnesses including interstitial pneumonia, cystic fibrosis, sickle cell disease, and primary ciliary dyskinesia

Exclusion Criteria

Immigration or death of the patient.
Patient dissatisfaction in continuing the treatment.
In case of other infectious or chronic diseases during the research period.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Degree of asthma control, interleukin 13, blood eosinophil percentage, forced expiratory volume, peak expiratory flow, forced vital capacity. Timepoint: At the beginning of the study and two months after the intervention. Method of measurement: Asthma control test(ACT), spirometry, CBC diff, IL13 human kit.